Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shock waves aim to soothe arthritic knees without surgery

NCT ID NCT06833372

Symptom relief Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether extracorporeal shock wave therapy can reduce pain and improve function in people with knee arthritis. 72 adults with persistent knee pain will receive either shock wave therapy or a daily exercise program. Researchers will measure pain levels and joint function over time to see if the shock wave approach offers meaningful relief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
extracorporeal shock wave therapy
What this could lead to
If it works, this could offer a non-surgical option to ease knee arthritis pain and improve mobility.
What could go wrong
This is a small, early-stage trial with only 72 participants. The treatment may not provide lasting relief or work better than exercise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 72 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * persistent knee pain for at least 3 months, measured with a VAS scale of 4 or higher, * clinical and radiological diagnosis confirming knee osteoarthritis grade 2 and 3 based on the Kellgren-Lawrence system, * no history of physical therapy in the last 3 months, * no infections, tumors in the treatment area of the knee, * no pathology other than osteoarthritis that could cause knee pain, * no pathology of the lumbar spine or hip that could refer knee pain, * free from any condition that prevents participation in exercise or physical therapy willing to participate regularly in the treatment programs were included in the study. Exclusion Criteria: * inability to walk, * a history of clinically symptomatic spinal stenosis or lumbar radiculopathy, * evidence of a neurological disorder based on history or physical examination, * generalized pain or fibromyalgia, * secondary osteoarthritis (to metabolic or rheumatologic disease), * administration of intra-articular injections (anesthetic, hyaluronic acid, cortisone) of the knee in the last 6 months, * use of NSAIDs, paracetamol or topical agents in the previous week, * a previous history of surgery involving the knee joint, * contraindications to physical therapy (PM, epilepsy, neoplasia, coagulopathy, pregnancy).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arthritis of knee are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arthritis of knee

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Policlinico di Bari

    RECRUITING

    Bari, 70124, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.